Literature DB >> 464575

Influence of probenecid on serum levels and urinary excretion of cinoxacin.

N Rodriguez, P O Madsen, P G Welling.   

Abstract

Serum levels and urinary excretion of cinoxacin were examined in healthy individuals after a two-step intravenous infusion in the presence and absence of probenecid. After dosing cinoxacin alone, steady-state serum levels were approached in 1 h and were maintained for an additional 2 h with a reduced infusion rate. After probenecid pretreatment, serum levels of cinoxacin continued to increase during 3 h of infusion, reaching levels approximately double those obtained with cinoxacin alone. The mean elimination half-life of cinoxacin from serum was increased from 1.3 to 3.5 h in the presence of probenecid, and renal clearance was significantly reduced, with 46% of dosed drug appearing in 7-h urines of probenecid-treated subjects compared with 68% in subjects receiving cinoxacin alone. Probenecid had no apparent influence on cinoxacin distribution in the body but caused a significant decrease in the rate of cinoxacin extrarenal elimination, possibly due to competition for a common metabolic pathway.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 464575      PMCID: PMC352685          DOI: 10.1128/AAC.15.3.465

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

Review 1.  RENAL TUBULAR MECHANISMS FOR EXCRETION OF ORGANIC ACIDS AND BASES.

Authors:  I M WEINER; G H MUDGE
Journal:  Am J Med       Date:  1964-05       Impact factor: 4.965

2.  FACTORS INFLUENCING RENAL EXCRETION OF FOREIGN ORGANIC ACIDS.

Authors:  I M WEINER; K C BLANCHARD; G H MUDGE
Journal:  Am J Physiol       Date:  1964-11

3.  The physiological disposition of probenecid, including renal clearance, in man, studied by an improved method for its estimation in biological material.

Authors:  P G DAYTON; T F YU; W CHEN; L BERGER; L A WEST; A B GUTMAN
Journal:  J Pharmacol Exp Ther       Date:  1963-06       Impact factor: 4.030

4.  On the mechanism of action of probenecid on renal tubular secretion.

Authors:  I M WEINER; J A WASHINGTON; G H MUDGE
Journal:  Bull Johns Hopkins Hosp       Date:  1960-06

5.  'Benemid,' p-(di-n-propylsulfamyl)-benzoic acid; its renal affinity and its elimination.

Authors:  K H BEYER; H F RUSSO; E K TILLSON; A K MILLER; W F VERWEY; S R GASS
Journal:  Am J Physiol       Date:  1951-09

6.  Compound 64716, a new synthetic antibacterial agent.

Authors:  W E Wick; D A Preston; W A White; R S Gordee
Journal:  Antimicrob Agents Chemother       Date:  1973-10       Impact factor: 5.191

7.  Cinoxacin: in vitro antibacterial studies of a new synthetic organic acid.

Authors:  R M Lumish; C W Norden
Journal:  Antimicrob Agents Chemother       Date:  1975-02       Impact factor: 5.191

8.  Antibacterial activity of cinoxacin in vitro.

Authors:  H Giamarellou; G G Jackson
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

9.  Pharmacodynamics of cefazolin in the presence of normal and impaired renal function.

Authors:  M F Rein; F B Westervelt; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1973-09       Impact factor: 5.191

10.  Cinoxacin: pharmacokinetics and the effect of probenecid.

Authors:  K S Israel; H R Black; R L Nelson; M K Brunson; J F Nash; G L Brier; J D Wolney
Journal:  J Clin Pharmacol       Date:  1978-10       Impact factor: 3.126

View more
  7 in total

1.  Renal handling of fleroxacin in rabbits, dogs, and humans.

Authors:  K Shiba; A Saito; J Shimada; S Hori; M Kaji; T Miyahara; H Kusajima; S Kaneko; S Saito; T Ooie
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

2.  Mechanism of renal excretion of AM-715, a new quinolonecarboxylic acid derivative, in rabbits, dogs, and humans.

Authors:  J Shimada; T Yamaji; Y Ueda; H Uchida; H Kusajima; T Irikura
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

3.  The effect of probenecid on the pharmacokinetics and distribution of cefoxitin in healthy volunteers.

Authors:  D S Reeves; D W Bullock; M J Bywater; H A Holt; L O White; D P Thornhill
Journal:  Br J Clin Pharmacol       Date:  1981-04       Impact factor: 4.335

4.  Comparative pharmacokinetic profiles of cinoxacin and pipemidic acid in humans.

Authors:  J M Brogard; F Comte; J Lavillaureix
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1983 Jul-Sep       Impact factor: 2.441

Review 5.  Cinoxacin. A review of its pharmacological properties and therapeutic efficacy in the treatment of urinary tract infections.

Authors:  T S Sisca; R C Heel; J A Romankiewicz
Journal:  Drugs       Date:  1983-06       Impact factor: 9.546

6.  Effect of orally administered probenecid on the pharmacokinetics of cefoxitin.

Authors:  P H Vlasses; A M Holbrook; J J Schrogie; J D Rogers; R K Ferguson; W B Abrams
Journal:  Antimicrob Agents Chemother       Date:  1980-05       Impact factor: 5.191

7.  Pharmacokinetics: metabolism and renal excretion of quinolones in man.

Authors:  T B Vree; W J Wijnands; P J Guelen; A M Baars; Y A Hekster
Journal:  Pharm Weekbl Sci       Date:  1986-02-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.